CYC Cyclopharm Limited
Healthcare · Medical Devices
· website
· 109 employees
$0.56
52wk 0.45 – 1.29
Overall
—
Value
—
Growth
—
Health
—
Quality
—
Momentum
—
Dividend
—
Price
About Cyclopharm Limited
Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, the United States, and internationally. The company operates Technegas which offers diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism and other respiratory conditions. It is also involved in the research and development; and distribution of third-party products to the diagnostic imaging sector. The company serves nuclear medicine departments. Cyclopharm Limited was founded in 1986 and is based in Kingsgrove, Australia.
Fundamental trends
Financial statements
Loading…
Key metrics
Market cap
$69.78M
P/E (trailing)
—
P/E (forward)
-8.02
EPS (trailing)
-0.16
Dividend yield
—
Payout ratio
0.0%
Beta
0.59
EV / EBITDA
-4.29
Price / Book
2.27
ROE
-49.3%
Operating margin
-51.8%
Net margin
-53.3%
Total cash
$6.63M
Total debt
$7.74M
Current ratio
2.53
Debt / Equity
0.29
Free cash flow
$-13.32M
Avg volume
148,398
Latest annual results
(FY ending 31 Dec 2025)
- Revenue$16.69M
- Gross profit$2.22M
- Operating income-$33.82M
- Net income-$17.22M
- Diluted EPS-0.16
- Free cash flow-$19.44M
- Net debt$1.11M